CeBIL – RIBS Symposium: At the Cutting Edge: New Developments in the Law of Biomedicine
This one-day symposium, co-hosted by CeBIL and the network on the Regulation and Innovation in the Biosciences (RIBS), aims to address contemporaneous issues emerging in the field of biomedicine. Law profoundly shapes, limits, and enables the way that new biomedical technology advances. This conference will consider cutting-edge legal developments in four broad biomedical areas of current interest: (1) the interaction between intellectual property, collaboration, and open science; (2) pricing and access to pharmaceuticals; (3) equity, inclusion, and bias in new technology, including big data and AI; and (4) technologies that alter reproduction and the human body.
Presenters will include leading legal scholars from across the United States and Europe, and could be relevant and interesting to legal practitioners, regulators and policymakers, biomedical scientists with an interest in law and policy, and anyone curious about how science is changing medicine and how the law is affecting that process.
Time: 12 June 2019, 08:30 – 16:30
Venue: Auditorium 4A-0-69, ground floor, Njalsgade 76, 2300 Copenhagen S
Certificate of participation
This event fulfills the requirements of the Danish Bar and Law Society for continuing legal education. Please tick the relevant box in the registration form if you wish to receive a certificate for the whole event (issued in Danish only).
Please register no later than 10 June at 22:00 using this registration form.
All inquiries concerning academic issues relating to the symposium should be addressed to Neethu Rajam at firstname.lastname@example.org.
All other inquiries concerning the conference should be addressed to Maryna Pagels, at email@example.com.
Novo Nordisk Foundation
CeBIL is supported by a grant of
DKK 35 million from the Novo Nordisk Foundation.